Can the Herpes Virus kill Cancer?

"Recently, scientists at the Institute of Cancer Research in London have been conducting successful trials with a skin cancer drug called T-VEC, a genetically engineered version of the herpes simplex virus which only replicates in cancer cells while leaving healthy tissues intact. In the latest T-VEC trial, it was given to 436 patients suffering from inoperable melanoma. And though the drug is still not licensed, the results have been promising so far, and with any luck drugs like T-VEC will be able to fight other forms of cancer, too."

More – including a video – you'll find here at DiscoveryNews.